.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Teva
Accenture
Deloitte
Cipla
Moodys
Chubb
AstraZeneca
Fish and Richardson

Generated: July 23, 2017

DrugPatentWatch Database Preview

Ceftizoxime sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for ceftizoxime sodium and what is the scope of ceftizoxime sodium freedom to operate?

Ceftizoxime sodium
is the generic ingredient in three branded drugs marketed by Astellas and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ceftizoxime sodium.

Summary for Generic Name: ceftizoxime sodium

Tradenames:3
Patents:1
Applicants:1
NDAs:3
Drug Master File Entries: see list5
Bulk Api Vendors: see list37
Clinical Trials: see list2,361
Patent Applications: see list846
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ceftizoxime sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas
CEFIZOX IN PLASTIC CONTAINER
ceftizoxime sodium
INJECTABLE;INJECTION050589-003Apr 13, 1995DISCNNoNo► Subscribe► Subscribe
Astellas
CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
ceftizoxime sodium
INJECTABLE;INJECTION050589-001Oct 3, 1984DISCNNoNo► Subscribe► Subscribe
Astellas
CEFIZOX
ceftizoxime sodium
INJECTABLE;INJECTION050560-001Sep 15, 1983DISCNNoNo► Subscribe► Subscribe
Astellas
CEFIZOX
ceftizoxime sodium
INJECTABLE;INJECTION050560-003Sep 15, 1983DISCNNoNo► Subscribe► Subscribe
Astellas
CEFIZOX
ceftizoxime sodium
INJECTABLE;INJECTION050560-005Mar 19, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Cipla
Moodys
Novartis
Farmers Insurance
US Department of Justice
Mallinckrodt
Daiichi Sankyo
US Army
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot